fluconazole has been researched along with Lung Diseases, Interstitial in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaiba, R | 1 |
| O'Neill, E | 1 |
| Lakshmi, S | 1 |
| Schreiber, J | 1 |
| Göring, HD | 1 |
| Rosahl, W | 1 |
| Strüben, C | 1 |
| Lakotta, W | 1 |
| Amthor, M | 1 |
2 other studies available for fluconazole and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Pulmonary cryptococcosis complicating interstitial lung disease in a patient with systemic lupus erythematosus.
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Cryptococcosis; Cryptococcus neoformans; Female; Fl | 2019 |
Interstitial lung disease induced by endogenous Candida albicans.
Topics: Antifungal Agents; Antigens, Fungal; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Imm | 2001 |